Alnylam Pharmaceuticals, Inc. ( ALNY) - Stock Earnings
ALNY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | 206.0 million USD | 1.2 billion USD |
| 2026Q2 | 164.5 million USD | 1.3 billion USD |
| 2026Q3 | 2.2 billion USD | 1.5 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ALNY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -440.2 million USD | 1.8 billion USD |
| 2024 | -278.2 million USD | 2.2 billion USD |
| 2025 | 313.7 million USD | 3.7 billion USD |
| 2026 Est. | — | — |
ALNY
Price: $165.60
52 week price:
Earnings Per Share: 19.80 USD
P/E Ratio: 8.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 712302
Ebitda: -143.6 millionMarket Capitalization: 20.9 billion